/CNW/ - Novartis Canada is pleased to announce the winners of the 2024 Novartis Oncology Young Canadian Investigator Awards (NOYCIA), an annual national...
Psoriatic arthritis is a chronic, autoimmune disease form of arthritis that causes joint inflammation (swelling, pain, stiffness) and occurs with skin...
/CNW/ - Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that Health Canada has granted Cosentyx® (secukinumab) with a Notice of...
These three companies have track records that should please investors.
The dividend is just one reason to buy these stocks.
A double beat on the latest quarterly results and raised guidance made investors happy.
Stocks that traded heavily or had substantial price changes on Tuesday: Novartis, Danaher rise; Nucor, Cadence Design Systems fall
NVS earnings call for the period ending March 31, 2024.
These income stocks look like good options at current levels.